Table 2 The incidence of erythrocytosis and polyglobulia (based on haematology parameters measured in 2012) in C1-INH-HAE patients who have never been treated with danazol, vs. in healthy controls
From: The effect of long-term danazol treatment on haematological parameters in hereditary angioedema
C1-INH-HAE patients never treated with danazol (n = 51) | Healthy controls (n = 210) | ||
|---|---|---|---|
Erythrocytosis | Males | 0 | 2 |
Females | 1 | 6 | |
No erythrocytosis | Males | 21 | 87 |
Females | 29 | 115 | |
Polyglobulia | Males | 0 | 0 |
Females | 0 | 1 | |
No polyglobulia | Males | 21 | 89 |
Females | 30 | 120 |